Latest

Alzheimer’s disease

·July 21, 2026·8 min read

Study Maps Accelerated Brain Aging Signatures Across 9 Conditions

Measuring Predictive Age Difference (PAD), the team found that Alzheimer’s disease and mild cognitive impairment showed the highest accelerated brain aging, followed by psychiatric disorders and substance addiction.

Featured Neurology Neuroscience

·July 16, 2026·13 min read

Long Sleep Hours Link to Elevated Alzheimer’s Blood Protein

A new study utilizes Restricted Cubic Splines to establish a robust non-linear association between long sleep duration and elevated plasma p-tau181.

Featured Neurology Neuroscience

·July 15, 2026·14 min read

Blood Test Accurately Predicts Five-Year Alzheimer’s Risk

The analysis reveals that asymptomatic individuals presenting with very high baseline p-tau217 concentrations face an absolute 38% risk of developing cognitive impairment within 5 years, escalating to 78% within 10 years.

This shows a head, a leaf, and a bottle of oil.

Featured Neurology Neuroscience

·July 14, 2026·9 min read

Purified THC/CBD Oil Dramatically Lowers Dementia Agitation

A new study demonstrates that a specialized oral THC/CBD medical oil formulation significantly and rapidly reduces end-of-life agitation in late-stage dementia patients.

Featured Neurology Neuroscience

·July 13, 2026·10 min read

Open-Source AI Tools for Alzheimer’s

Researchers launched three open-source AI tools, AI Literature and Data Synthesis, Dark Data Analyzer, and Reviewer Three, to combat the 99% failure rate of Alzheimer's clinical trials.

Featured Neurology Neuroscience

·July 12, 2026·10 min read

Decreasing Productivity Can Precede a Dementia Diagnosis by Years

A new study demonstrates that early-onset dementia is associated with severe work productivity losses up to 15 years before a formal diagnosis.

Featured Neurology Neuroscience

·July 10, 2026·10 min read

Myelin Damage Triggers Abnormal Brain Rhythms During Sleep

Demyelination triggers abnormal, epileptiform electrical spikes coupled with Stage 2 NREM sleep spindles and induces a severe slowing of rhythmic REM sleep oscillations, establishing overnight sleep recordings as a non-invasive biomarker for tracking MS and Alzheimer's progression.

Featured Neurology Neuroscience

·July 9, 2026·8 min read

ATP Platform Adaptive Trial Speeds Up Dementia Research

UCSF launches the historic ATP clinical trial, testing a combination of donanemab and the AADvac1 vaccine to treat pre-symptomatic Alzheimer's.

Featured Neurology Neuroscience

·July 8, 2026·11 min read

Alcohol Alters Brain Flexibility Based on Hidden Dementia Markings

Alcohol interacts differently with amyloid-beta and tau pathologies in the brain's corticostriatal circuit.

Featured Neurology Neuroscience

·July 6, 2026·9 min read

Invisible Tire Dust Hijacks Alzheimer’s Predictor Genes

A new study links the tire rubber pollutant 6PPD-quinone (6PPD-Q) to Alzheimer's disease pathways. Using machine learning and network pharmacology, the team discovered that 6PPD-Q binds to three core predictor genes in the brain, inducing oxidative stress, neuroinflammation, and synaptic disruption.

Featured Neurology Neuroscience

·July 6, 2026·12 min read

TB Vaccine Flushes Alzheimer’s Amyloid

The BCG vaccine remodels the human brain’s immune environment via trained immunity. Tracking older adults over one year, researchers demonstrated that BCG enhances central nervous system immune cell responsiveness and lowers amyloid-beta levels in the cerebrospinal fluid of healthy individuals, offering an early preventative pathway against Alzheimer's disease.